JPRN-jRCT2080221113未知3 期
A multicenter, open-label, long-term safety study of aripiprazoleorally administered over 52 weeks in patients who complete a short-term treatment study of aripiprazole in pediatric patients with schizophrenia (031-09-003 study)
适应症
试验速览
- 阶段
- 3 期
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 13age old 至 <= 17age old（—）
- 性别
- All
入选标准
- •1) Patients with a diagnosis of schizophrenia according to DSM-IV-TR
- •2) Male and female patients aged 13-17 years
- •3) Patients completing the 031-09-003 study
排除标准
- •1) Patients who have a diagnosis of any other disease except schizophrenia, according to DSM-IV-TR
- •2) Patients who fall under a contraindication listed in the ABILIFY package insert
研究者
相似试验
进行中（未招募）
1 期
Peanut allergy studyEUCTR2017-001334-26-ITAIMMUNE THERAPEUTICS1,100
未知
3 期
ong-term Treatment Study of CDP870 without coadministration of MTX in Japanese RA patientsRheumatoid ArthritisJPRN-jRCT2080220676Astellas Pharma Inc.130
未知
3 期
ong-term Treatment Study of CDP870 as Add-on Medication to MTX in Japanese RA patientsRheumatoid ArthritisJPRN-jRCT2080220675Astellas Pharma Inc.222
进行中（未招募）
不适用
A multicenter, single-arm, open-label safety study of lenalidomide plus dexamethasone in previously treated subjects with Multiple Myeloma.Previously treated subjects with Multiple MyelomaEUCTR2006-002517-12-ATCelgene International Sàrl1,400
进行中（未招募）
不适用
Trial to assess the long-term safety of tretinoin clindamycin phosphate gel in patients from 12 to less than 18 years of age with acne vulgaris.Treatment of Acne vulgarisMedDRA version: 14.1Level: HLTClassification code 10000497Term: AcnesSystem Organ Class: 10040785 - Skin and subcutaneous tissue disordersEUCTR2010-022912-37-Outside-EU/EEAMedicis Pharmaceutical Corporation442